PM
56
2
VIX
55
-5
EQT
56
2
GD
41
2
ITW
33
2
PLD
33
-4
MSI
47
4
AKAM
37
3
NDAQ
50
4
PRU
40
-4
AMP
52
6
BWA
38
-6
CSCO
67
3
NFLX
59
-2
STT
59
14
AEP
56
5
HD
37
2
LLY
37
4
AMGN
33
-3
IP
54
4
PM
56
2
VIX
55
-5
EQT
56
2
GD
41
2
ITW
33
2
PLD
33
-4
MSI
47
4
AKAM
37
3
NDAQ
50
4
PRU
40
-4
AMP
52
6
BWA
38
-6
CSCO
67
3
NFLX
59
-2
STT
59
14
AEP
56
5
HD
37
2
LLY
37
4
AMGN
33
-3
IP
54
4
Financhill
Back

VanEck Office and Commercial REIT ETF Vs. Janux Therapeutics Industry Stock Comparison

Sell
27

DESK
VanEck Office and Commercial REIT ETF

Last Price:
$40.87
Seasonality Move:
-6.31%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
27
VanEck Office and Commercial REIT ETF (DESK) is a Sell

Is VanEck Office and Commercial REIT ETF a Buy, Sell or Hold?

  • The current VanEck Office and Commercial REIT ETF [DESK] share price is $41.10. The Score for DESK is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • DESK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DESK Stock Price Chart

What is VanEck Office and Commercial REIT ETF's stock price today?

  • The VanEck Office and Commercial REIT ETF share price today is $41.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DESK is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

DESK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 32.11 Sell
Chaikin Money Flow: 1803 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.41 - 45.55) Sell
Bollinger Bands (100): (42.21 - 45.73) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

DESK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.5 Sell
20-day SMA: 43.69 Sell
50-day SMA: 44.6 Sell
200-day SMA: 40.21 Buy
8-day EMA: 42.32 Sell
20-day EMA: 43.27 Sell
50-day EMA: 43.94 Sell
200-day EMA: 41.16 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

VanEck Office and Commercial REIT ETF Earnings Growth & DESK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

VanEck Office and Commercial REIT ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):